GREENLAND MINES LTD Investment Income, Interest
GREENLAND MINES LTD (GRML) reported Investment Income, Interest of $251.66 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-23.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2024-05-23
- GREENLAND MINES LTD investment income, interest for the quarter ending 2024-03-31 was $251.66K, a 79.87% decline year-over-year.
- GREENLAND MINES LTD investment income, interest for the quarter ending 2023-03-31 was $1.25M.
- GREENLAND MINES LTD investment income, interest for the quarter ending 2022-12-31 was $1.20M.
- GREENLAND MINES LTD investment income, interest for the quarter ending 2022-09-30 was $312.20K.
- GREENLAND MINES LTD investment income, interest for fiscal 2023 was $3.36M, a 103.08% increase from fiscal 2022.
- GREENLAND MINES LTD investment income, interest for fiscal 2022 was $1.66M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-03-31 | $251.66K 10-Q · filed 2024-05-23 | |||||
| 2023-12-31 | $3.36M 10-K · filed 2024-04-17 | |||||
| 2023-03-31 | $1.25M 10-Q · filed 2024-05-23 | $798.52K 10-Q · filed 2023-05-24 | $2.45M derived: sum of 2 quarters · filed 2024-05-23 | $2.76M derived: sum of 3 quarters · filed 2024-05-23 | $2.91M derived: sum of 4 quarters · filed 2024-05-23 | |
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | $1.51M derived: sum of 2 quarters · filed 2024-04-17 | $1.66M derived: sum of 3 quarters · filed 2024-04-17 | $1.66M 10-K · filed 2024-04-17 | $1.28M 10-K · filed 2023-04-10 | |
| 2022-09-30 | $312.20K 10-Q · filed 2022-11-14 | $458.60K derived: sum of 2 quarters · filed 2022-11-14 | $458.60K 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $146.40K 10-Q · filed 2022-08-15 | $146.40K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |